| Year |
Citation |
Score |
| 2022 |
Tilk S, Tkachenko S, Curtis C, Petrov DA, McFarland CD. Most cancers carry a substantial deleterious load due to Hill-Robertson interference. Elife. 11. PMID 36047771 DOI: 10.7554/eLife.67790 |
0.653 |
|
| 2021 |
Li C, Lin WY, Rizvi H, Cai H, McFarland CD, Rogers ZN, Yousefi M, Winters IP, Rudin CM, Petrov DA, Winslow MM. Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma. Cancer Research. PMID 34215621 DOI: 10.1158/0008-5472.CAN-21-0716 |
0.714 |
|
| 2021 |
Cai H, Chew SK, Li C, Tsai MK, Andrejka L, Murray CW, Hughes NW, Shuldiner EG, Ashkin EL, Tang R, Hung KL, Chen LC, Lee SYC, Yousefi M, Lin WY, ... ... McFarland CD, et al. A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer. Cancer Discovery. PMID 33608386 DOI: 10.1158/2159-8290.CD-20-1325 |
0.772 |
|
| 2020 |
Cai H, Li C, Chew SK, Yousefi M, Foggetti G, Lin W, Rogers ZN, Winters IP, McFarland CD, Politi K, Swanton C, Petrov DA, Winslow MM. Abstract IA26: Multiplexed functional cancer genomics Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-Ia26 |
0.78 |
|
| 2018 |
Rogers ZN, McFarland CD, Winters IP, Seoane JA, Brady JJ, Yoon S, Curtis C, Petrov DA, Winslow MM. Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nature Genetics. PMID 29610476 DOI: 10.1038/S41588-018-0083-2 |
0.752 |
|
| 2018 |
Winters IP, Rogers ZN, McFarland CD, Lalgudi PV, Chiou S, Kay MA, Petrov D, Winslow MM. Abstract IA03: Functional lung cancer genomics through in vivo genome editing Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-Ia03 |
0.78 |
|
| 2017 |
Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA, Winslow MM. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nature Communications. 8: 2053. PMID 29233960 DOI: 10.1038/S41467-017-01519-Y |
0.774 |
|
| 2017 |
McFarland C, Yaglom JA, Wojtkowiak JW, Scott J, Morse DL, Sherman MY, Mirny L. The damaging effect of passenger mutations on cancer progression. Cancer Research. PMID 28536279 DOI: 10.1158/0008-5472.Can-15-3283-T |
0.701 |
|
| 2017 |
Rogers ZN, McFarland CD, Winters IP, Naranjo S, Chuang CH, Petrov D, Winslow MM. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nature Methods. PMID 28530655 DOI: 10.1038/Nmeth.4297 |
0.76 |
|
| 2016 |
Grüner BM, Schulze CJ, Yang D, Ogasawara D, Dix MM, Rogers ZN, Chuang CH, McFarland CD, Chiou SH, Brown JM, Cravatt BF, Bogyo M, Winslow MM. An in vivo multiplexed small-molecule screening platform. Nature Methods. PMID 27617390 DOI: 10.1038/Nmeth.3992 |
0.569 |
|
| 2014 |
McFarland CD, Mirny LA, Korolev KS. Tug-of-war between driver and passenger mutations in cancer and other adaptive processes. Proceedings of the National Academy of Sciences of the United States of America. 111: 15138-43. PMID 25277973 DOI: 10.1073/Pnas.1404341111 |
0.679 |
|
| 2014 |
Yaglom JA, McFarland C, Mirny L, Sherman MY. Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer. Oncotarget. 5: 8367-78. PMID 25252808 DOI: 10.18632/Oncotarget.2259 |
0.553 |
|
| 2013 |
McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA. Impact of deleterious passenger mutations on cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 110: 2910-5. PMID 23388632 DOI: 10.1073/Pnas.1213968110 |
0.692 |
|
| 2011 |
McFarland CD, Scott JG, Basanta D, Anderson ARA, Mirny LA. Abstract 24: A genetic model of metastatic evolution: Driver and passenger mutations affect metastatic fitness Cancer Research. 71: 24-24. DOI: 10.1158/1538-7445.Am2011-24 |
0.678 |
|
| Show low-probability matches. |